Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood
Sponsored by Unity Health Toronto
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the Participation Requirements?
Healthcare provider Inclusion Criteria:
- Are at least 18 years of age
- Are able to provide informed consent
- Are paid employees of the study site(s)
- Are able to perform the study procedures outlined in the protocol
Healthcare provider Exclusion Criteria:
• Have used or watched someone use the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test
Patient Inclusion Criteria:
- Are at least 18 years of age
- Are able to provide informed consent
- Agree to provide accurate medical history
- Are able to provide up to 20mL blood by venipuncture, an oral fluid and a fingerstick
blood sample
- Agree to undergo testing with the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test
- Patients with the known HIV positive status (diagnosis must be within five years of
the study visit)
- Patients with unknown HIV status (last HIV negative test must be greater than 6 months
prior to study visit)
Patient Exclusion Criteria:
- Are site employees
- Are in the judgment of the investigator unable to complete the study or are unlikely
to comply with the study protocol; or
- Have been previously enrolled in this study.